We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CMR Improves Diagnosis of Cardiac Involvement in Lupus

By MedImaging International staff writers
Posted on 17 Sep 2018
Print article
Image: A new study suggests that cardiac MRI can help detect lupus before symptoms appear (Photo courtesy of GE Healthcare).
Image: A new study suggests that cardiac MRI can help detect lupus before symptoms appear (Photo courtesy of GE Healthcare).
Cardiac magnetic resonance (CMR) can be used to diagnose systemic lupus erythematosus (SLE) ahead of clinical symptoms, according to a new study.

Researchers at Goethe University Hospital (KGU; Frankfurt am Main, Germany), University Hospital Tübingen (Germany), and other institutions conducted a study in 92 consecutive patients with SLE who were free of cardiac symptoms, and undergoing screening for cardiac involvement; study participants were age and gender-matched to 78 non-SLE controls. The aim of the study was to evaluate associations between high-sensitive troponin T (hs-TropT), a marker of myocardial injury, and cardiovascular involvement using CMR with a 3T magnetic resonance imaging (MRI) scanner.

The results showed that in SLE patients, hs-TropT was significantly and independently associated with higher native T1 and T2 MRI values, aortic and ventricular stiffness, and reduced global longitudinal strain. No relationships were found between hs-TropT and age, gender, cardiovascular risk factors, duration of systemic disease, cardiac structure or function, or late gadolinium enhancement. According to the researchers, the new CMR diagnostic method can accurately detect SLE disease presence, stage, and severity. The study was published on August 4, 2018, in Annals of the Rheumatic Diseases.

“Patients with SLE have a high prevalence of subclinical myocardial injury as demonstrated by raised high-sensitive troponin levels. CMR with T2 mapping reveals myocardial edema as the strongest predictor of hs-TropT release, underscoring the inflammatory interstitial remodeling as the main mechanism of injury,” concluded lead author Valentina Puntmann, MD, PhD, of KGU, and colleagues. “Patients without active myocardial inflammation demonstrate diffuse interstitial remodeling and increased vascular stiffness. These findings substantiate the role of CMR in screening of subclinical cardiac involvement.”

SLE is an incurable systemic autoimmune disease that can affect any part of the body, but most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system. SLE occurs nine times more often in women than in men, is also more common in those of non-European descent. The disease is unpredictable, with periods of illness (called flares) alternating with remissions. Treatment involves preventing flares and reducing their severity and duration using corticosteroids and anti-malarial drugs.

Related Links:
Goethe University Hospital
University Hospital Tübingen

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Breast Imaging Workstation
SecurView
New
Ultrasound System
Acclarix AX9

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.